Intrathecal baclofen: expanding treatment options for hypertonicity.
Adequate assessment and treatment of hypertonia has remained a challenging problem for physicians. Differentiating between the various characteristics of hypertonicity can lead to improved treatment options. While oral medications, focal chemo-denervation, chemical neurolysis and orthopedic surgeries continue to play a role in the management of pathologic tone, intrathecal delivery of baclofen has proven to be a safe and effective treatment in the clinical setting of hypertonia.